First Tracks Biotherapeutics, Inc. (TRAX) earnings
Quarterly results of First Tracks Biotherapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 6 quarters, the latest results release and when the next one is expected.
Next earnings date
First Tracks Biotherapeutics, Inc. is expected to report around January 29, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) First Tracks Biotherapeutics, Inc. reported revenue of - and a net loss of $31.4M.
Diluted earnings per share were -$0.88.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | -$31.4M | -$0.88 |
| Q2 FY2026 | - | - | -$33.4M | -$0.95 |
| Q1 FY2026 | - | - | -$50.5M | - |
| Q3 FY2026 | - | - | -$41.9M | -$1.50 |
| Q2 FY2026 | - | - | -$42.4M | -$1.47 |
| Q1 FY2026 | - | - | -$47.2M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is First Tracks Biotherapeutics, Inc.'s next earnings date?
First Tracks Biotherapeutics, Inc. is expected to report around January 29, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Get an email when TRAX reports
Follow TRAX and we email you its next results the day they are filed, with the numbers explained.